Novel test supports vaccine development studies critical to aiding researchersin understanding immunity levels and disease progression WALTHAM, Mass. – January 14, 2021 – PerkinElmer today announced that its EUROIMMUN business has launched a SARS-CoV-2 Interferon Gamma Release Assay (IGRA) for Research Use Only (RUO) to determine the activity of T-cells reactive to SARS-CoV-2, the pathogen... Read more
Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute CHELMSFORD, Mass., Jan. 12, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that GENEWIZ, the Company’s genomics analysis business, has been awarded one of six Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI,... Read more
WALTHAM, Mass., Dec. 31, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research.... Read more
Automatable and reliable COVID-19 test rounds out Company’s menu of offerings for acute diagnostics of the virus WALTHAM, Mass. – December 16, 2020 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein. The assay adds to the Company’s broad product... Read more
MENLO PARK, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced initial findings from the company’s research collaboration with Labcorp that is focused on SARS-CoV-2 and the related immune response to COVID-19. Announced in April 2020, PacBio and... Read more
Solution designed for complex matrices, delivering high sensitivity, single sample prep and high throughput processing WHAT: PerkinElmer , a global leader committed to innovating for a healthier world, today announced its MaxSignal™ HTS Total Aflatoxins and DON ELISA Kits featuring automated Read more
Quantifying IgG is critical component to test population-wide vaccination effectiveness Read more
CHELMSFORD, Mass., Dec. 8, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today with great sadness that Mr. A. Clinton Allen, Director, passed away unexpectedly on December 6, 2020. Mr. Allen served on Brooks’ Board of Directors since 2003. He was 76. “We are all saddened by the sudden passing of our friend and longtime board member,... Read more
CHELMSFORD, Mass., Dec. 3, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that it has acquired Trans-Hit Biomarkers Inc. (THB), a worldwide biospecimen procurement service provider based in Montreal Canada. THB has an extensive collection capability for biospecimens and clinical samples through a worldwide partner network of clinical sites and biobanks. THB is enabled... Read more
Germantown, Maryland, and Hilden, Germany, November 16, 2020 –QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that will help healthcare professionals quickly identify and differentiate between patients with common seasonal respiratory infections and COVID-19. With the Northern Hemisphere in the grip of flu... Read more